India · English
Emcure Pharma Approves Merger Of Two Wholly-Owned Subsidiaries, Zuventus Healthcare And Emcutix Biopharmaceuticals
Mumbai: Emcure Pharmaceuticals Limited on Monday announced that its Board of Directors approved a Composite Scheme of Amalgamation for two wholly-owned subsidiaries, Zuventus Healthcare Limited and Emcutix Biopharmaceuticals Limited, with the parent company. Board Meeting Details The Board of Directors met on October 12, 2026, commencing at 9:45 a.m. (IST) and concluding at 10:10 a.m. (IST) to…
Read the full report at Free Press Journal →
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.